Shih-Yen Weng, Detlef Schuppan  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Intermyocellular fat depot
Pathological roles of purinergic signaling in the liver
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
The inflammasome in liver disease
Volume 47, Issue 3, Pages (September 2017)
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Vascular biology of metabolic syndrome
Obesity Heats Up Adipose Tissue Lymphocytes
Metabolic stress-induced joint inflammation and osteoarthritis
The Role of CNS Fuel Sensing in Energy and Glucose Regulation
Figure 3 Candidate signalling pathways of irisin in hepatocytes
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Roles for Chemokines in Liver Disease
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Gal3 Links Inflammation and Insulin Resistance
eCB pathways involved in obesity-/HFD-associated CKD
ChREBP in NASH – A liver transcription factor comes in from the cold
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Signalling pathways in alcohol-induced liver inflammation
Nat. Rev. Endocrinol. doi: /nrendo
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Hua V. Lin, Domenico Accili  Cell Metabolism 
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
The Origins and Drivers of Insulin Resistance
IKKɛ: A Bridge between Obesity and Inflammation
Metabolic triggered inflammation in osteoarthritis
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions  Batya B. Davidovici, Naveed Sattar,
Volume 134, Issue 4, Pages (April 2008)
Volume 57, Issue 5, Pages (November 2012)
Veronika Lukacs-Kornek, Detlef Schuppan  Journal of Hepatology 
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
Volume 7, Issue 6, Pages (June 2008)
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Volume 140, Issue 6, Pages (March 2010)
Figure 3 Regulation of insulin sensitivity by innate immune cells
Konstantinos G. Michalakis, M.D., James H. Segars, M.D. 
Cannabinoid signaling and liver therapeutics
Karel J. van Erpecum, Frank G. Schaap  Journal of Hepatology 
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Volume 62, Issue 6, Pages (June 2015)
NASH animal models: Are we there yet?
Fishing Out a Sensor for Anti-inflammatory Oils
Subhra K. Biswas, Raffaella Bonecchi  Cell Metabolism 
Insulin Resistance in the Defense against Obesity
A New “Immunological” Role for Adipocytes in Obesity
Volume 14, Issue 2, Pages (August 2011)
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease  Michal Pawlak,
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Risk factors and mechanisms of non-alcoholic steatohepatitis
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Inflammatory pathways in alcoholic steatohepatitis
Fig. 1. Hypothesis: mitochondrial dysfunction in adipocytes may be a primary cause of adipose tissue inflammation. Hypertrophic adipocytes in obesity or.
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Tissue Immunometabolism: Development, Physiology, and Pathobiology
Volume 58, Issue 4, Pages (April 2013)
Lipid Sensing and Insulin Resistance in the Brain
Volume 61, Issue 2, Pages (August 2014)
Sander Lefere, Frank Tacke  JHEP Reports 
Macrophages, Immunity, and Metabolic Disease
IL-1β Activation as a Response to Metabolic Disturbances
NF-κB, Inflammation, and Metabolic Disease
Presentation transcript:

AMPK regulates macrophage polarization in adipose tissue inflammation and NASH  Shih-Yen Weng, Detlef Schuppan  Journal of Hepatology  Volume 58, Issue 3, Pages 619-621 (March 2013) DOI: 10.1016/j.jhep.2012.09.031 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Scheme depicting the role of macrophage polarization in obesity-induced inflammation and insulin resistance. Circulating monocytes are recruited into the liver and adipose tissues where they differentiate into either M1 or M2 macrophages. Obesity and a HFD (as well as carbohydrate overload) cause a vicious circle of insulin resistance and increased free fatty acids, with resultant hepatocyte mitochondrial dysfunction and M1 macrophage polarization in the liver and adipose tissues. These obesity-related Arg1 lowiNOS highCD11c+adipose tissue macrophages are characterized by enhanced expression of inflammatory cytokines, chemokines and mediators such as TNFα, IL-6, IL-8, CCL2, IL-1β, and iNOS [12], all factors that suppress insulin signaling and de-repress downstream gluconeogenesis via activation of glucose-6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase 1 (PCK1). This proinflammatory M1 polarization is usually controlled by adiponectin, AMPK, PPARγ, and PPARδ, all regulators of energy homeostasis and inducers of regulated fatty acid oxidation and metabolism, skewing macrophage polarization toward the anti-inflammatory M2 phenotype. ACC, acyl-CoA carboxylase; FA, fatty acid. Journal of Hepatology 2013 58, 619-621DOI: (10.1016/j.jhep.2012.09.031) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions